Effects of Rat C-peptide-II on Lipolysis and Glucose Consumption in Cultured Rat Adipose Tissue

Abstract

Existing data show that C-peptide (CP) prevents or ameliorates diabetes-related complications mainly by improving microcirculation and perhaps metabolism. Although effects of CP on muscle glucose consumption are relatively well studied, its effects on adipose tissue, a key organ involved in metabolism, are not well known. Therefore, the aim of this study was to examine the effects of CP on basal and stimulated lipolysis and glucose consumption in rat retroperitoneal (RP) adipose tissue, using an ex-vivo organ culture setting. The RP adipose tissue was excised from adult male rats, minced and subjected to ex-vivo culture for 24 h. The tissue fragments were then weighted and distributed into a 24-well culture plate. The wells were left untreated (basal) or treated with insulin or isoproternol (ISO, stimulated) and incubated in the absence or presence of CP, insulin or a combination of the both peptides. Levels of lipolysis and tissue glucose consumption were determined by glycerol and glucose concentrations measurement in the infranatant conditioned media collected from each well. The CP, like insulin, induced an insignificant reduction in basal lipolysis. While insulin significantly reduced the ISO-stimulated lipolysis, CP was ineffective. Tissue glucose consumption was significantly stimulated by insulin, but was not affected by CP. However, in the presence of CP, inhibitory effect on ISO-stimulated lipolysis and stimulatory effect on glucose consumption of insulin were significantly diminished. Our data suggest that CP may conditionally modulate certain metabolic actions of insulin in RP adipose tissue. These modulations may contribute to fine-tuning of body metabolism under physiologic or pathologic conditions.

Key words

C-peptide - lipolysis - metabolism - adipose tissue - rat

References

• 1 Wahren J, Ekberg K, Jornvall H. C-peptide is a bioactive peptide.  Diabetologia. 2007;  50 503-509
• 2 Wahren J. C-peptide: new findings and therapeutic implications in diabetes.  Clin Physiol Funct Imaging. 2004;  24 180-189
• 3 Tsimaratos M, Roger F, Chabardes D. et al . C-Peptide stimulates Na⁺, K⁺-ATPase activity via PKC alpha in rat medullary thick ascending limb.  Diabetologia. 2003;  46 124-131
• 4 Wallerath T, Kunt T, Forst T. et al . Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide.  Nitric oxide. 2003;  9 95-102
• 5 Shafqat J, Juntti-Berggren L, Zhong Z. et al . Proinsulin C-peptide and its analogues induce intracellular Ca⁺⁺ increases in human renal tubular cells.  Cell Mol Life Sci. 2002;  59 1185-1189
• 6 Nordquist L, Palm F, Andresen TB. Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action.  Biologics. 2008;  2 441-452
• 7 Uruska A, Araszkiewicz A, Zozulinska-Ziolkiewicz D. et al . Insulin resistance is associated with microangiopathy in type 1 diabetic patients treated with intensive insulin therapy from the onset of disease.  Exp Clin Endocrinol Diabetes. 2010;  118 478-484
• 8 Wu W, Oshida Y, Yang WP. et al . Effect of C-peptide administration on whole body glucose utilization in STZ-induced diabetic rats.  Acta Physiol Scand. 1996;  157 253-258
• 9 Zierath JR, Handberg A, Tally M. et al . C-peptide stimulates glucose transport in isolated human skeletal muscle independent of insulin receptor and tyrosine kinase activation.  Diabetologia. 1996;  39 306-313
• 10 Zierath JR, Galuska D, Johansson BL. et al . Effect of human C-peptide on glucose transport in in vitro incubated human skeletal muscle.  Diabetologia. 1991;  34 899-901
• 11 Johansson BL, Sjoberg S, Wahren J. The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients.  Diabetologia. 1992;  35 121-128
• 12 Grunberger G, Qiang X, Li Z. et al . Molecular basis for the insulinomimetic effects of C-peptide.  Diabetologia. 2001;  44 1247-1257
• 13 Rigler R, Pramanik A, Jonasson P. et al . Specific binding of proinsulin C-peptide to human cell membranes.  PNAS. 1999;  96 13318-13323
• 14 Ido Y, Vindigni A, Chang K. et al . Prevension of vascular and nural dysfunction in diabetic rats by C-peptide.  Sience. 1997;  277 563-566
• 15 Arner P. Human fat cell lipolysis: Biochemistry, regulation and clinical role.  Best Pract Res Clin Endocrinol Metab. 2005;  19 471-482
• 16 Adachi Y, Sakurai H. Insulin-mimetic vanadyl(IV) complexes as evaluated by both glucose-uptake and inhibition of free fatty acids (FFA) – release in isolated rat adipocytes.  Chem Pharm Bull. 2004;  52 428-433
• 17 Accorsi PA, Gamberoni M, Isani G. et al . Leptin does not seem to influence glucose uptake by bovine mammary explants.  J Physiol Pharmacol. 2005;  56 689-698
• 18 Moustaid N, Jones BH, Taylor JW. Insulin increase lipogenic enzyme activity in human adipocytes in primary culture.  J Nutr. 1996;  126 865-870
• 19 Rodbell M. Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis.  J Biol Chem. 1964;  239 375-380
• 20 Nakano T, Scott PG. Purification and characterization of gelatinase produced by fibroblasts from human gingival.  Biochem Cell Biol. 1986;  64 387-393
• 21 Kitabchi AE. The biological and immunological properties of pork and beef insulin, proinsulin, and connecting peptides.  J Clin Inves. 1970;  49 979-987
• 22 Solomon SS, Brush JS, Kitabchi AE. Antilipolytic activity of insulin and proinsulin on ACTH and cyclic nucleotide-induced lipolysis in the isolated adipose cell of rat.  Biochem Biophys Acta. 1970;  218 167-169
• 23 Yu SS, Kitabchi AE. Biological activity of proinsulin and related polypeptides in the fat tissue.  J Biol Chem. 1973;  248 3753-3761
• 24 Steiner DF, Bell GI, Rubenstein AH. et al .Chemistry and biosynthesis of the islet hormones.. In: DeGroot L, Jameson JL Endocrinology 5th ed. Philadelphia: Elsevier; 2006: 925-960
• 25 Grunberger G, Sima AAF. The C-peptide signaling.  Exp Diab Res. 2004;  5 25-36
• 26 Horwitz DL, Starr JI, Mako ME. et al . Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.  J Clin Invest. 1975;  55 1278-1283
• 27 Wahren J, Ekberg K, Johansson J. et al . Role of C-peptide in human physiology.  Am J Physiol Endocrinol Metab. 2000;  278 759-768
• 28 Ghorbani A, Varedi M, Hadjzadeh MA. et al . Type-1 diabetes induces depot-specific alterations in adipocyte diameter and mass of adipose tissues in the rat.  Exp Clin Endocrinol Diabetes. 2010;  118 442-448
• 29 Varedi M, Tredget EE, Ghahary A. et al . Stress-relaxation and contraction of a collagen matrix induces expression of TGF-β and triggers apoptosis in dermal fibroblasts.  Biochem Cell Biol. 2000;  78 427-436
• 30 Foster DW, Esser V. Ketoacidosis and hyperosmolar coma.. In: DeGroot L, Jameson JL, editors. Endocrinology 5 th ed. Philadelphia: Elsevier; 2006: 1185-1195
• 31 Kunt T, Schneider S, Pfutzner A. et al . The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type I diabetes mellitus.  Diabetologia. 1999;  42 465-471
• 32 Nordquist L, Moe E, Sjoquist M. The C-peptide fragment EVARQ reduces glomerular hyperfiltration in streptozotocin – induced diabetic rats.  Diabetes Metab Res Rev. 2007;  23 400-405

Correspondence